Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 7/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 6/20 | 0.41 |
| ▸ | HDAC3 | O15379 | 4/20 | 0.41 |
| ▸ | HDAC4 | P56524 | 3/20 | 0.41 |
| ▸ | HDAC7 | Q8WUI4 | 3/20 | 0.41 |
| ▸ | HDAC10 | Q969S8 | 3/20 | 0.41 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.41 |
| ▸ | HDAC9 | Q9UKV0 | 3/20 | 0.41 |
| ▸ | HDAC5 | Q9UQL6 | 3/20 | 0.41 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.40 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.40 |
| ▸ | TYR | P14679 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7153095 | 0.99 | HDAC1 (0.41) | HDAC1HDAC2HDAC3HDAC4HDAC7 | |
| Hydrochloric Acid SCHEMBL7122876 | 0.75 | APOBEC3A (0.39) | HDAC1HDAC3APOBEC3AAPOBEC3GMAPT | |
| SCHEMBL2923779 | 0.74 | APOBEC3A (0.40) | HDAC1HDAC3APOBEC3AAPOBEC3GMAPT | |
| Hydrochloric Acid SCHEMBL29140955 | 0.70 | NAAA (0.61) | HDAC1HDAC2HDAC3HDAC4HDAC7 | |
| SCHEMBL13500651 | 0.70 | KDM4E (0.47) | HDAC1HDAC2HDAC3HDAC4HDAC7 | |
| SCHEMBL16450052 | 0.70 | AURKA (0.41) | KDM4EGAALMNAMAPTHTT | |
| SCHEMBL3578888 | 0.69 | LMNA (0.53) | KDM4EGAALMNAMAPTHTT | |
| SCHEMBL7163885 | 0.68 | AURKA (0.56) | KDM4EGAALMNAMAPTSMN1; SMN2 | |
| SCHEMBL12876249 | 0.68 | L3MBTL1 (0.64) | APOBEC3AAPOBEC3GLMNAMEN1KMT2A | |
| SCHEMBL2928566 | 0.68 | HDAC3 (0.49) | HDAC1HDAC2HDAC3HDAC4HDAC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6528650-B2 | Mixture containing coupler | L'OREAL S.A. (FR) | 2003-03-04 | — | — | US | claimed |
| US-20030019050-A9 | Novel cationic 4-hydroxyindoles, their use for the oxidation dyeing of keratinous fibers, dyeing compositions, and methods of dyeing | L'OREAL | 2003-01-30 | — | — | US | claimed |
| US-20020032937-A1 | Novel cationic 4-hydroxyindoles, their use for the oxidation dyeing of keratinous fibers, dyeing compositions, and methods of dyeing | L'OREAL | 2002-03-21 | — | — | US | claimed |
| US-6306181-B1 | FOR DYEING HUMAN HAIR | L'OREAL (FR) | 2001-10-23 | — | — | US | claimed |
| EP-0989128-B1 | 4-Hydroxyindoles kationic and their use for oxidation dyeing of keratinous fibres | OREAL (FR) | 2001-03-21 | — | — | EP | claimed |
| US-20030019050-A9 | Novel cationic 4-hydroxyindoles, their use for the oxidation dyeing of keratinous fibers, dyeing compositions, and methods of dyeing | L'OREAL | 2003-01-30 | — | — | US | disclosed |
| US-20020032937-A1 | Novel cationic 4-hydroxyindoles, their use for the oxidation dyeing of keratinous fibers, dyeing compositions, and methods of dyeing | L'OREAL | 2002-03-21 | — | — | US | disclosed |
| US-6306181-B1 | FOR DYEING HUMAN HAIR | L'OREAL (FR) | 2001-10-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020032937-A1 | Novel cationic 4-hydroxyindoles, their use for the oxidation dyeing of keratinous fibers, dyeing compositions, and methods of dyeing | KRT18, KMO, H1-5 | HDAC1 701/4885HDAC2 652/4885HDAC3 526/4885 |
| US-20030019050-A9 | Novel cationic 4-hydroxyindoles, their use for the oxidation dyeing of keratinous fibers, dyeing compositions, and methods of dyeing | KRT18, KMO, H1-5 | HDAC1 701/4885HDAC2 652/4885HDAC3 526/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.